Mirae Asset Global ETFs Holdings
PRAX icon

Mirae Asset Global ETFs Holdings’s Praxis Precision Medicines PRAX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.12M Sell
27,185
-559
-2% -$177K 0.01% 698
2026
Q1 		$8.89M Buy
27,744
+2,185
+9% +$676K 0.01% 674
2025
Q4 		$7.54M Buy
25,559
+2,723
+12% +$507K 0.01% 697
2025
Q3 		$1.21M Sell
22,836
-1,037
-4% -$50.3K ﹤0.01% 1378
2025
Q2 		$1.01M Buy
23,873
+12,165
+104% +$463K ﹤0.01% 1438
2025
Q1 		$444K Buy
11,708
+573
+5% +$35.8K ﹤0.01% 1935
2024
Q4 		$856K Buy
11,135
+258
+2% +$18.7K ﹤0.01% 1630
2024
Q3 		$626K Buy
10,877
+9,320
+599% +$503K ﹤0.01% 1808
2024
Q2 		$61.9K Buy
+1,557
New +$73.6K ﹤0.01% 2732

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PRAX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Praxis Precision Medicines (PRAX) stake by 2% in Q2 2026, selling an estimated $177K and leaving 27,185 shares worth $9.12M. The position accounts for 0.01% of the portfolio, ranked #698.

Mirae Asset Global ETFs Holdings first reported a position in PRAX in Q2 2024 and has held it in 9 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 27,185 shares of Praxis Precision Medicines worth $9.12M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 559 Praxis Precision Medicines shares in Q2 2026, an estimated $177K.
  • Praxis Precision Medicines made up 0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #698 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Praxis Precision Medicines in Q2 2024 and has held it in 9 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.